Pancreatic ductal adenocarcinoma (pda) is a challenging disease and the fourth leading cause of cancer death worldwide. It has a poor prognosis, with less than 2% of patients surviving more than five years.
More than 80% of subjects are diagnosed with metastatic or unresectable disease and are mainly treated with palliative chemotherapy for symptom control and survival prolongation. Read more . . .